HSCARG inhibits activation of NF-κB by interacting with IκB kinase-β

Journal of Cell Science

Volumn 122, Issue 22, 2009, Pages 4081-4088

  Gan, Qini ^a   Li, Tingting ^a   Hu, Bin ^a   Lian, Min ^a   Zheng, Xiaofeng ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

HSCARG; IKK ; NF B; Phosphorylation

Indexed keywords

I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; NMRA LIKE FAMILY DOMAIN CONTAINING PROTEIN 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME REPRESSION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

CELL LINE; DOWN-REGULATION; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; INTERLEUKIN-1; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTORS;

EID: 70849100656     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.054007     Document Type: Article

References (49)

1. Baldwin, A. S., Jr (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
2. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. and Baltimore, D. (1995). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376, 167-170.
3. Brummelkamp, T. R., Nijman, S. M., Dirac, A. M. and Bernards, R. (2003). Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424, 797-801.
4. Carter, R. S., Pennington, K. N., Ungurait, B. J., Arrate, P. and Ballard, D. W. (2003). Signal-induced ubiquitination of I kappaB Kinase-beta. J. Biol. Chem. 278, 48903-48906.
5. Carter, R. S., Pennington, K. N., Arrate, P., Oltz, E. M. and Ballard, D. W. (2005). Site-specific monoubiquitination of IkappaB kinase IKKbeta regulates its phosphorylation and persistent activation. J. Biol. Chem. 280, 43272-43279.
6. Chen, F., Castranova, V., Shi, X. and Demers, L. M. (1999). New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem. 45, 7-17.
7. Chen, L. F. and Greene, W. C. (2004). Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell. Biol. 5, 392-401.
8. Delhase, M., Hayakawa, M., Chen, Y. and Karin, M. (1999). Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284, 309-313.
9. DiDonato, J. A., Mercurio, F. and Karin, M. (1995). Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol. Cell. Biol. 15, 1302-1311.
10. Duan, Y., Guan, X., Ge, J., Quan, D., Zhuo, Y., Ye, H. and Shao, T. (2008). Cationic nano-copolymers mediated IKKbeta targeting siRNA inhibit the proliferation of human Tenon's capsule fibroblasts in vitro. Mol. Vis. 14, 2616-2628.
11. Finco, T. S. and Baldwin, A. S. (1995). Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 3, 263-272.
12. Ghosh, S., May, M. J. and Kopp, E. B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
13. Green, D. R. (2003). Death and NF-kappaB in T cell activation: life at the edge. Mol. Cell 11, 551-552.
14. Harhaj, E. W. and Sun, S. C. (1999). IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J. Biol. Chem. 274, 22911-22914.
15. Hoffmann, A., Natoli, G. and Ghosh, G. (2006). Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25, 6706-6716.
16. Hong, X., Xu, L., Li, X., Zhai, Z. and Shu, H. (2001). CSN3 interacts with IKKgamma and inhibits TNF- but not IL-1-induced NF-kappaB activation. FEBS Lett. 499, 133-136.
17. Hsu, H., Huang, J., Shu, H. B., Baichwal, V. and Goeddel, D. V. (1996). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396.
18. Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R. and Karin, M. (1999). Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284, 316-320.
19. Jobin, C. and Sartor, R. B. (2000). The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. Am. J. Physiol. Cell Physiol. 278, C451-C462.
20. Karin, M. and Ben-Neriah, Y. (2000). Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18, 621-663.
21. Karin, M. and Lin, A. (2002). NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227.
22. Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israel, A., Wallach, D. and Courtois, G. (2003). The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424, 801-805.
23. Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P. and Ma, A. (2000). Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289, 2350-2354.
24. Lee, J. C., Won, S. J., Chao, C. L., Wu, F. L., Liu, H. S., Ling, P., Lin, C. N. and Su, C. L. (2008). Morusin induces apoptosis and suppresses NF-kappaB activity in human colorectal cancer HT-29 cells. Biochem. Biophys. Res. Commun. 372, 236-242.
25. Li, H. Y., Liu, H., Wang, C. H., Zhang, J. Y., Man, J. H., Gao, Y. F., Zhang, P. J., Li, W. H., Zhao, J., Pan, X. et al. (2008). Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1. Nat. Immunol. 9, 533-541.
26. Li, Q. and Verma, I. M. (2002). NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2, 725-734.
27. Li, Q., Van Antwerp, D., Mercurio, F., Lee, K. F. and Verma, I. M. (1999). Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284, 321-325.
28. Li, S., Wang, L., Berman, M. A., Zhang, Y. and Dorf, M. E. (2006). RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. Mol. Cell 24, 497-509.
29. Lin, W. W. and Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175-1183.
30. Liu, Z. G., Hsu, H., Goeddel, D. V. and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87, 565-576.
31. Luedde, T., Heinrichsdorff, J., de Lorenzi, R., De Vos, R., Roskams, T. and Pasparakis, M. (2008). IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver. Proc. Natl. Acad. Sci. USA 105, 9733-9738.
32. Mayo, M. W. and Baldwin, A. S. (2000). The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim. Biophys. Acta. 1470, M55-M62.
33. Nakano, H., Shindo, M., Sakon, S., Nishinaka, S., Mihara, M., Yagita, H. and Okumura, K. (1998). Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. USA 95, 3537-3542.
34. Pahl, H. L. (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866.
35. Perkins, N. D. (2000). The Rel/NF-kappa B family: friend and foe. Trends Biochem. Sci. 25, 434-440.
36. Schmid, J. A. and Birbach, A. (2008). IkappaB kinase beta (IKKbeta/IKK2/IKBKB)-a key molecule in signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev. 19, 157-165.
37. Schmitz, M. L. and Baeuerle, P. A. (1991). The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 10, 3805-3817.
38. Silverman, N. and Maniatis, T. (2001). NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15, 2321-2342.
39. Simmonds, R. E. and Foxwell, B. M. (2008). Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology (Oxford) 47, 584-590.
40. Tak, P. P. and Firestein, G. S. (2001). NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 107, 7-11.
41. Tanaka, T., Grusby, M. J. and Kaisho, T. (2007). PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat. Immunol. 8, 584-591.
42. Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A. and Mosialos, G. (2003). CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424, 793-796.
43. Werner, S. L., Barken, D. and Hoffmann, A. (2005). Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309, 1857-1861.
44. Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L. et al. (2004). De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694-699.
45. Xie, Q. W., Kashiwabara, Y. and Nathan, C. (1994). Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 4705-4708.
46. Yamamoto, Y. and Gaynor, R. B. (2001). Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr. Mol. Med. 1, 287-296.
47. Zandi, E. and Karin, M. (1999). Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex. Mol. Cell. Biol. 19, 4547-4551.
48. Zhao, Y., Zhang, J., Li, H., Li, Y., Ren, J., Luo, M. and Zheng, X. (2008). An NADPH sensor protein (HSCARG) down-regulates nitric oxide synthesis by association with argininosuccinate synthetase and is essential for epithelial cell viability. J. Biol. Chem. 283, 11004-11013.
49. Zheng, X., Dai, X., Zhao, Y., Chen, Q., Lu, F., Yao, D., Yu, Q., Liu, X., Zhang, C., Gu, X. et al. (2007). Restructuring of the dinucleotide-binding fold in an NADP(H) sensor protein. Proc. Natl. Acad. Sci. USA 104, 8809-8814.